A novel and effective hyperthermia method for Schistosomiasis japonica prevention and treatment

October 15, 2015, Science China Press
Schematic version of local skin hyperthermia. Credit: Science China Press

Schistosomiasis, or bilharzia, is a common parasitic disease which can cause bladder dysfunction and hematuria, and even correlate with bladder cancer and increase HIV susceptibility with urogenital lesions. Globally, it is estimated that more than 240 million people are infected. Within endemic areas, children carry the heaviest burden of infection. Its treatment depends intensively on PZQ, which has replaced other antischistosomal drugs and become a regular first-line therapy. However, given that PZQ has been widely used for almost 40 years, the emergence of schistosomal resistance under drug selection pressure has received much attention. With the increase in schistosomiasis, the serious threat of PZQ resistance requires adequate monitoring of current mass drug administration programs. Thus, novel alternative interventions are in high demand, and in this study, we use hyperthermia to prevent and treat heat-sensitive schistosomiasis.

High temperature has been used to treat illnesses dating back to as early as 5000 years ago. Magnetic hyperthermia is a new clinical therapy approved for treatment of tumor cells . Hyperthermia treatment can shrink tumors via the selective killing of cancer cells by damaging proteins and cellular structures. Recently, similar successful therapies have also been reported in treating acne vulgaris, mild-to-moderate inflammatory acne and cutaneous leishmaniasis.

A skin-hyperthermia device (Figure 1) designed by Tsinghua university was used to target migrating skin schistosomula and to expand on the in vitro pre-treatment findings on cercariae, which is a novel method for treating the skin phase of a parasite infection.

The data revealed that with increased thermal dosages, the survival rate of cercariae decreased from 70 percent to 0 percent, which indicated the preventing effect of hyperthermia (P < 0.05). When treated with thermal dosages above 45°C, the survival rate of cercariae ranged from a 50 percent reduction to almost 100 percent compared with control groups. Moreover, when the S. japonicum infected mice were treated by heating the cercarial-contact region of skin, the worm reduction rates (WRR) reached 83.1 percent (P < 0.05).

A novel and effective hyperthermia method for Schistosomiasis japonica prevention and treatment
The microwave hyperthermia device (A) and the course of intraperitoneal hyperthermia treatment (B and C). Credit: Science China Press

The sensitivity of adult schistosomes to heat was also investigated with a microwave hyperthermia device (Figure 2A). The WRR, hepatic shift rates and egg reduction rates were 23.7 percent, 40 percent and 30 percent respectively after treatment with thermal dosages of 42~43 °C for 20 minutes. Although it failed to exceed the group of PZQ, the results suggest that hyperthermia could be an effective prevention method.

Explore further: Optune device approved for newly diagnosed brain cancer

More information: YANG Huixia , et al. "A novel and effective hyperthermia method for Schistosomiasis japonica prevention and treatment," Science Bulletin, 2015, 60(16): 1461-1464. link.springer.com/article/10.1 … %2Fs11434-015-0867-z

Related Stories

Optune device approved for newly diagnosed brain cancer

October 6, 2015
(HealthDay)—The U.S. Food and Drug Administration on Monday expanded its approval for the Optune device to include newly diagnosed glioblastoma multiforme, an aggressive brain cancer.

Examining water-borne parasites that cause intestinal schistosomiasis

March 19, 2015
Water is essential for life on Earth. It is crucial for environmental and human health, necessary for food and energy security, and indispensable for continued urbanization and industry. One in nine people lacks access to ...

Antibody treatment efficacious in psoriasis

September 30, 2015
An experimental, biologic treatment, brodalumab, achieved 100 percent reduction in psoriasis symptoms in twice as many patients as a second, commonly used treatment, according to the results of a multicenter clinical trial ...

Recommended for you

Ambitious global virome project could mark end of pandemic era

February 23, 2018
Rather than wait for viruses like Ebola, SARS and Zika to become outbreaks that force the world to react, a new global initiative seeks to proactively identify, prepare for and stop viral threats before they become pandemics.

Forecasting antibiotic resistance with a 'weather map' of local data

February 23, 2018
The resistance that infectious microbes have to antibiotics makes it difficult for physicians to confidently select the right drug to treat an infection. And that resistance is dynamic: It changes from year to year and varies ...

Study reveals how kidney disease happens

February 22, 2018
Monash researchers have solved a mystery, revealing how certain immune cells work together to instigate autoimmune kidney disease.

Scientists gain new insight on how antibodies interact with widespread respiratory virus

February 22, 2018
Scientists have found and characterized the activity of four antibodies produced by the human immune system that target an important protein found in respiratory syncytial virus (RSV), according to new research published ...

Past encounters with the flu shape vaccine response

February 20, 2018
New research on why the influenza vaccine was only modestly effective in recent years shows that immune history with the flu influences a person's response to the vaccine.

Building better tiny kidneys to test drugs and help people avoid dialysis

February 16, 2018
A free online kidney atlas built by USC researchers empowers stem cell scientists everywhere to generate more human-like tiny kidneys for testing new drugs and creating renal replacement therapies.

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.